Strategics deals, or deals between two corporations, got a boost as industrial conglomerate Danaher Corp. said it would buy electronic testing company Textronix Inc. for $2.8 billion. That marked a 34-percent premium to Textronix’s closing stock price on Friday.

That strategic link-up followed news on Friday that biotechnology company Biogen Idex Inc. put itself up for sale. Biogen said billionaire investor Carl Icahn was one interested party, but analysts suggested the most logical suitors would be large drug companies that are desperate to fill gaps in their product pipelines and have ample cash to spend on acquisitions.

Meanwhile, Saks Inc. has been attracting interest from a mix of strategic and private equity suitors, according to retail industry trade publication WWD. The report cited Icelandic firm Baugur Group, as well as Cerberus Capital Management and Permira. The companies could not be immediately reached for comment.

And despite the pull back in private equity deal activity, yet another company appears to have put itself in play. Children’s Place said on Monday that it’s ex-CEO may bid for the company. The announcement, made through a filing, came after reports on Friday that the company was up for sale.